RELATION OF LIPID PEROXIDES TO MACROVASCULAR DISEASE IN TYPE-2 DIABETES

被引:89
作者
VELAZQUEZ, E [1 ]
WINOCOUR, PH [1 ]
KESTEVEN, P [1 ]
ALBERTI, KGMM [1 ]
LAKER, MF [1 ]
机构
[1] UNIV NEWCASTLE UPON TYNE,HUMAN DIABET & METAB RES CTR,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
关键词
LIPID PEROXIDES; LIPIDS; APOLIPOPROTEINS; MACROVASCULAR DISEASE; TYPE-2; DIABETES;
D O I
10.1111/j.1464-5491.1991.tb01695.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipid peroxides are thought to be formed by free radicals and may play an important role in the development of atheromatous vascular disease. We have investigated the relationship between lipids, lipoproteins, coagulation factors, and lipid peroxides (measured as thiobarbituric acid reacting species (TBARS) in Type 2 diabetic patients with macrovascular disease. Eighteen diabetic and 20 non-diabetic subjects with clinical evidence of ischaemic heart disease and/or peripheral vascular disease were investigated, together with 28 healthy subjects without evidence of vascular disease. TBARS concentrations in non-diabetic (mean 5.0 (95% CI 4.5-5.7) mu-mol l-1) and diabetic groups (5.6 (5.1-6.0) mu-mol l-1) with macrovascular disease were not significantly different although values were higher in both groups of patients with vascular disease by comparison with control subjects (2.7 (2.4-3.1) mu-mol l-1, p < 0.001). Significant univariate correlations between TBARS concentrations and measures of blood glucose control (fructosamine, blood glucose and HbA1) were found for all 66 subjects (r = 0.35-0.42, p < 0.01-p < 0.001), although no independent association between these parameters and TBARS was demonstrated in multiple regression analysis. In addition, TBARS levels were significantly correlated in univariate analysis with the apolipoprotein (apo) AI:apoB ratio (r = -0.56, p < 0.001), total cholesterol:high density lipoprotein cholesterol ratio (r = 0.52, p < 0.001), apoB (r = 0.51, p < 0.001), low density lipoprotein cholesterol (r = 0.40, p < 0.001), serum total triglyceride (r = 0.46, p < 0.001), apoAI (r = -0.35, p < 0.01) and serum total cholesterol (r = 0.39, p < 0.001). Multiple regression analysis of continuous variables showed that apoB (p < 0.001), age (p < 0.001), and apoAI (p = 0.008) were independently associated with serum TBARS although these associations disappeared if macrovascular disease was added to the regression equation as a categorical variable. Our data support previous studies which demonstrate increased serum concentrations of TBARS in subjects with macrovascular disease but suggest that levels are similarly elevated in diabetic and non-diabetic subjects.
引用
收藏
页码:752 / 758
页数:7
相关论文
共 45 条
[1]  
Entmacher PS, Root HF, Marks HH., Longevity of diabetic patients in recent years, Diabetes, 13, pp. 373-377, (1964)
[2]  
Canda OP., Pathogenesis of macrovascular disease in human diabetes, Diabetes, 29, pp. 931-942, (1980)
[3]  
Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organization Multinational Study of vascular disease in diabetics, Diabetologia, 28, pp. 284-296, (1985)
[4]  
Gordon T., Castelli WP, Hjortland MC, Kannel WB, Dawber TR., Diabetes, blood lipids and the role of obesity in coronary heart disease risk for women: the Framingham Study, Ann Intern Med, 87, pp. 393-397, (1977)
[5]  
Howard BV., Lipoprotein metabolism in diabetes mellitus, J Lipid Res, 28, pp. 613-628, (1987)
[6]  
Steinberg D., Atherosclerosis from the view point of cell biology, Atherosclerosis—Developments, Complications and Treatment, pp. 3-20, (1987)
[7]  
Henning B., Chow CK., Lipid peroxidation and endothelial cell injury: implications in atherosclerosis, Free Radical Biol Med, 4, pp. 99-106, (1988)
[8]  
Stringer MD, Gorog PG, Freeman A., Kakkar VV., Lipid peroxides and atherosclerosis, Br Med J, 298, pp. 281-284, (1989)
[9]  
Huang Z-S, Lu FJ, Lee TK., Correlation between serum lipid peroxides and the lesion size in cerebrovascular disease, Clin Chim Acta, 173, pp. 325-330, (1988)
[10]  
Uysal M., Bulur H., Sener D., Oz H., Lipid peroxidation in patients with essential hypertension, Int J Clin Pharmacol Ther Toxicol, 24, pp. 474-476, (1986)